Dr. Malcolm Richardson is a Consultant Clinical Scientist in Medical Mycology with expertise in fungal infections, diagnostics, antifungal resistance, and environmental mycology. He plays a key role at the Mycology Reference Centre, affiliated with Manchester University NHS Foundation Trust at Wythenshawe Hospital. He is renowned for his work on aspergillosis, candidosis, dermatophytosis, and other mycological conditions.

Academic and Professional Background

• Current Position: Consultant Clinical Scientist in Medical Mycology, Manchester
• Honorary Roles:
  • Honorary Professor at Guangzhou Medical University, China (since 2019)
  • Honorary Professor, University of Manchester, UK (since 2009)
• Former Roles:
  • Ex-Director of Mycology Reference Centre, Manchester (2009–2020)
  • Editor-in-Chief, Critical Reviews in Microbiology (2008–2014)

Key Contributions and Achievements

• Publications: Over 480 papers, book chapters, and 17 textbooks, including Fungal Infection: Diagnosis and Management (4 editions).
• Citations: Google h-index of 77 and over 28,000 citations.
• Awards: Distinguished Service Award, International Society for Human and Animal Mycology (2022).

Research and Affiliations

• Research: Active researcher in the NIHR Manchester BRC Infection Theme.
• Leadership: Fellow of the Royal College of Pathologists, Royal Society of Biology, and European Confederation of Medical Mycology. Past President of the International Society for Human and Animal Mycology and President of the British Society for Medical Mycology (since 2022).

Industry and Consultancy

• Co-founder of Richardson Bio-Tech and founder of MoBiAir Diagnostics.
• Consultant to pharmaceutical and diagnostic companies, and member of key mycology research steering committees.

Dr. Richardson's career spans clinical mycology, research, and industry, significantly advancing the understanding and management of fungal infections.